Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.7175
-0.0027 (-0.37%)
At close: May 22, 2026, 4:00 PM EDT
0.7295
+0.0120 (1.67%)
After-hours: May 22, 2026, 5:41 PM EDT
Enlivex Market Cap
Enlivex has a market cap or net worth of $172.95 million as of May 22, 2026. Its market cap has increased by 596.45% in one year.
Market Cap
172.95M
Enterprise Value
167.84M
1-Year Change
596.45%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since March 26, 2019, Enlivex's market cap has increased from $101.63M to $172.95M, an increase of 70.18%. That is a compound annual growth rate of 7.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 173.60M | 4.00% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Karyopharm Therapeutics | 187.18M |
| Precision BioSciences | 187.07M |
| Polaryx Therapeutics | 183.22M |
| Acumen Pharmaceuticals | 182.74M |
| AN2 Therapeutics | 179.80M |
| Elicio Therapeutics | 178.44M |
| Oramed Pharmaceuticals | 177.15M |
| Tenaya Therapeutics | 174.05M |